Key Metrics of Legend Biotech
Revenue$75.7M▲ 0.0% YoYFY 2020
Operating income—
Net profit−$303M▲ 0.0% YoY
Shareholders' equity$280M
Market cap$3.7BLEGN · $18.90
Competitors10identified
About Legend Biotech
Sectors
Company details
- Website
- legendbiotech.cn
- Founded
- 2020
- Listed
- Nasdaq: LEGN (since 2020)
Operational Areas of Legend Biotech
Pharmaceuticals & Healthcare›Biotechnology & Vaccines
Company summary
Legal nameLegend Biotech Corporation
TickerLEGN
ExchangeNasdaq
CountryUnited States
SEC CIK0001801198
Listed since2020
IndustryBiotechnology: Pharmaceutical Preparations
SectorPharmaceuticals & Healthcare · Biotechnology & Vaccines
Websitehttp://www.legendbiotech.cn
US market & SEC filings
LEGN · Nasdaq · SEC CIK 0001801198
Last price · 24 Oct 2026
$18.90
+1.45%
Market cap$3.7B
P/E—On FY 2020 diluted EPS
Volume1,198,404
SectorHealth CareBiotechnology: Pharmaceutical Preparations
Country · IPOUnited StatesListed 2020
LEGN share price
Premium
Annual results (SEC EDGAR)
Revenue, operating income, net income, EPS, cash flow, assets, liabilities, equity and debt for every year filed with the SEC are part of the premium plan.
Sign in to continue See plans & pricingVendor checks & payment capacity
Sign in with access to company financials to review vendor evidence.
Registered office and contact
Registered officeMoling Subdistrict
GSTIN—
Email—
Websitehttp://www.legendbiotech.cn
Members / shareholders—
Directors and key people
Directors are read from the MGT-7 annual return and AOC-4 signatories.
Competitors of Legend Biotech
Competitors10identified
Countries1most in United States
Top competitors by location
| Company | Description | Domain | Founded | Location |
|---|---|---|---|---|
| Part of Vertex Pharmaceuticals. | vrtx.com | 1991 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | modernatx.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bd.com | — | United States | |
| Part of Illumina. | illumina.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | guardanthealth.com | 2018 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | revvity.com | — | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | exelixis.com | 2000 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | neurocrine.com | 1996 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | biomarin.com | 1999 | United States | |
| Biotechnology & Vaccines · Pharmaceuticals & Healthcare | bio-rad.com | 1980 | United States |
Charges (secured borrowings)
0 registered charges. Lenders, amounts and dates are part of the premium plan.
Statutory auditors
Auditors are read from the AOC-4 auditor's report section.
Business activities and related parties
biotechnology
Filings
No filings on record yet.